• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study).

作者信息

Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, Nagoh N, Kayaba K, Yamada S, Matsuo H

机构信息

Department of Internal Medicine, Wara National Health Insurance Hospital, Gifu, Japan.

出版信息

Am J Cardiol. 1995 Nov 1;76(12):928-32. doi: 10.1016/s0002-9149(99)80263-x.

DOI:10.1016/s0002-9149(99)80263-x
PMID:7484833
Abstract

An elevated serum level of lipoprotein(a) (Lp[a]) may be an independent risk factor for atherosclerotic disease, but the relation of Lp(a) to aortic valve (AV) sclerosis has not been determined. We measured serum concentrations of Lp(a) and investigated their relation to the presence of echocardiographic AV sclerosis in residents of a rural village in Japan. We measured serum Lp(a) levels in 347 men and 437 women aged 35 to 90 years (mean +/- SD: 62 +/- 11 years) who participated in mass screening examinations in Wara village, Gifu, Japan. AV sclerosis was assessed by long- and short-axis 2-dimensional echocardiographic views and continuous-wave Doppler echocardiography. AV sclerosis was graded as follows: 0 = normal AV; 1 = increased echo density; 2 = thickening or calcific deposits > or = 3 mm; and 3 = same as 2 with mildly restricted motion (pressure gradient < 16 mm Hg). Lp(a) levels ranged from < 1 mg/dl to 153 mg/dl. The 25th, 50th, and 75th percentile values were 7, 16, and 28 mg/dl, respectively. Lp(a) levels were significantly higher in women than in men (p < 0.01), and did not increase significantly with age. The prevalence of AV sclerosis (grades 2 and 3) increased significantly with age (p < 0.001). AV sclerosis was present in 65 (36.1%) of 180 subjects with Lp(a) levels > or = 30 mg/dl and in 77 (12.7%) of 604 subjects with Lp(a) levels < 30 mg/dl (p < 0.001). There were no significant differences in the prevalence of AV sclerosis in terms of sex, blood pressure, or levels of total cholesterol, high-density lipoprotein cholesterol, triglycerides, or blood sugar. We conclude that increased serum levels of Lp(a), as well as aging, are closely related to AV sclerosis.

摘要

相似文献

1
Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study).
Am J Cardiol. 1995 Nov 1;76(12):928-32. doi: 10.1016/s0002-9149(99)80263-x.
2
[Clinical significance of serum lipoprotein(a) in elderly patients with aortic valve sclerosis].血清脂蛋白(a)在老年主动脉瓣硬化患者中的临床意义
Nihon Ronen Igakkai Zasshi. 1998 Jun;35(6):444-50. doi: 10.3143/geriatrics.35.444.
3
Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.脂蛋白(a)与钙化性主动脉瓣狭窄:系统综述。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):496-502. doi: 10.1016/j.pcad.2020.06.002. Epub 2020 Jun 8.
4
Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.氧化磷脂、脂蛋白(a)与钙化性主动脉瓣狭窄的进展。
J Am Coll Cardiol. 2015 Sep 15;66(11):1236-1246. doi: 10.1016/j.jacc.2015.07.020.
5
Comparison of Lipoprotein(a)-Levels in Patients ≥70 Years of Age With Versus Without Aortic Valve Stenosis.70岁及以上有与无主动脉瓣狭窄患者脂蛋白(a)水平的比较。
Am J Cardiol. 2018 Aug 15;122(4):645-649. doi: 10.1016/j.amjcard.2018.04.046. Epub 2018 May 11.
6
Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.脂蛋白(a)是外周动脉疾病主动脉瓣和二尖瓣狭窄的一个危险因素。
Eur Heart J Cardiovasc Imaging. 2016 May;17(5):492-7. doi: 10.1093/ehjci/jev338. Epub 2016 Jan 12.
7
Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.接受经导管主动脉瓣置换术患者的脂蛋白(a)
Angiology. 2019 Apr;70(4):332-336. doi: 10.1177/0003319719826461. Epub 2019 Jan 30.
8
The Prevalence of Lipoprotein(a) Measurement and Degree of Elevation Among 2710 Patients With Calcific Aortic Valve Stenosis in an Academic Echocardiography Laboratory Setting.在一家学术性超声心动图实验室中,2710例钙化性主动脉瓣狭窄患者的脂蛋白(a)测量患病率及升高程度。
Angiology. 2017 Oct;68(9):795-798. doi: 10.1177/0003319716688415. Epub 2017 Jan 10.
9
Determinants of occurrence of aortic sclerosis in an aging population.老年人群主动脉硬化发生的决定因素。
JACC Cardiovasc Imaging. 2009 Aug;2(8):919-27. doi: 10.1016/j.jcmg.2009.03.016.
10
Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia.脂蛋白(a)水平与家族性高胆固醇血症无症状患者的主动脉瓣钙化有关。
J Intern Med. 2015 Aug;278(2):166-73. doi: 10.1111/joim.12335. Epub 2015 Jan 5.

引用本文的文献

1
Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy.糖尿病与钙化性主动脉瓣疾病:降糖药物作为潜在治疗方法的意义
Front Pharmacol. 2025 Apr 28;16:1583267. doi: 10.3389/fphar.2025.1583267. eCollection 2025.
2
The Prevalence of Coronary Artery Disease in Bicuspid Aortic Valve Patients: An Overview of the Literature.二叶式主动脉瓣患者冠状动脉疾病的患病率:文献综述
Aorta (Stamford). 2023 Dec;11(6):191-197. doi: 10.1055/s-0044-1785190. Epub 2024 May 2.
3
Lipoprotein(a) As a Potential Predictive Factor for Earlier Aortic Valve Replacement in Patients with Bicuspid Aortic Valve.
脂蛋白(a)作为二叶式主动脉瓣患者早期主动脉瓣置换的潜在预测因素。
Biomedicines. 2023 Jun 25;11(7):1823. doi: 10.3390/biomedicines11071823.
4
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis.脂蛋白(a)与钙化性主动脉瓣疾病的发生和进展:系统评价和荟萃分析。
Cardiovasc Res. 2023 Jul 6;119(8):1641-1655. doi: 10.1093/cvr/cvad062.
5
Lipoprotein(a): Its Association with Calcific Aortic Valve Stenosis, the Emerging RNA-Related Treatments and the Hope for a New Era in "Treating" Aortic Valve Calcification.脂蛋白(a):其与钙化性主动脉瓣狭窄的关联、新兴的RNA相关治疗方法以及“治疗”主动脉瓣钙化新时代的希望。
J Cardiovasc Dev Dis. 2023 Feb 23;10(3):96. doi: 10.3390/jcdd10030096.
6
Lipoprotein(a): Evidence for Role as a Causal Risk Factor in Cardiovascular Disease and Emerging Therapies.脂蛋白(a):作为心血管疾病因果风险因素的证据及新兴疗法
J Clin Med. 2022 Oct 13;11(20):6040. doi: 10.3390/jcm11206040.
7
Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease.脂蛋白(a),钙化性主动脉瓣疾病中的致命因素。
Front Cell Dev Biol. 2022 Jan 27;10:812368. doi: 10.3389/fcell.2022.812368. eCollection 2022.
8
Trends in testing and prevalence of elevated Lp(a) among patients with aortic valve stenosis.主动脉瓣狭窄患者脂蛋白(a)升高的检测和流行趋势。
Atherosclerosis. 2022 May;349:144-150. doi: 10.1016/j.atherosclerosis.2022.01.022. Epub 2022 Jan 31.
9
Increased Ca2+ influx through CaV1.2 drives aortic valve calcification.钙离子内流通过 Cav1.2 驱动主动脉瓣钙化。
JCI Insight. 2022 Mar 8;7(5):e155569. doi: 10.1172/jci.insight.155569.
10
Biomolecules Orchestrating Cardiovascular Calcification.生物分子调控心血管钙化。
Biomolecules. 2021 Oct 7;11(10):1482. doi: 10.3390/biom11101482.